MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

0.765 (-1.92%)
0

T-O (am): 0.780 (08:59:00)
T-O (pm): 0.000 (14:29:00)
Last updated: 17:00

Fundamental
Technical
Total Score

MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Historical Dividends

Financial Ratios

EPS 6.29 sen
Trailing PE (Sector Median: 20.7) 12.2
PEG 0.12
Altman Z 1.6
Beaver -0.002
Current Ratio 18.08
Debt-Equity (DE) Ratio 0.08
FCF Yield -1.34 %
Revenue QoQ -59.08 %
Revenue YoY 107.57 %
Profit QoQ 254.39 %
Profit YoY 342.72 %
Profit Margin (Sector Median: 7.4) 34.21 %
ROE (ROIC: 19.46) 19.46 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.31
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 0.85
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 2370000.0 units announced on 08 Aug 2022 at ~RM0.73

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 13 Jul 2022 at ~RM0.955

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 12 Jul 2022 at ~RM0.945

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05

TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83

TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78

Summary


Market Cap: 95 M.

Number of Shares: 124 M.

Adjusted Float: 83.8%.

Stock highly correlated with

GESHEN (88%)

VS (88%)

XOXNET (88%)

MERIDIAN (86%)

MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services

Sectors: Healthcare, Health Care Equipment & Services

Code: 0155

Website: http://www.mgrc.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 30-Sep-2021

Shareholder Value (M)
Phillip Securities (Hong Kong) Ltd 7.88
Liw Chai Yuk 7.47
Pixelvest Sdn Bhd 4.68
Chu Boon Lin 3.82
Goh Bian Soon 2.69
Kevin Tan Yean Khim 2.53
Saw Sooi Huat 2.41
Wong Wee Yong 2.03
Yeo Tsu Sin 2.0
Ping Hiow Yew 1.7
Mohd Rafael bin Mohd Shamsudin 1.69
Munirah binti Haji Abdul Hamid 1.68
Ooi Cyndy 1.48
Barclays Capital Securities Ltd 1.31
Ong San Leong 1.14
Liong Liuh Juin 1.07
Wong Chen How 1.05
Nor Azah binti Adnan 1.0
Foo Chai Lee 0.94
Albert Tan Yean Heong 0.92
Inertia Aif Sdn Bhd 0.9
Noraziah binti Adnan 0.88
Khoo Hai Chew 0.77
Shahril bin Shamsuddin 0.77
Societe Generale Paris 0.74
Choong Chee Yip 0.64
Tan Kok Aun 0.63

This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.